3D Printed Drugs Market Size Worth $269.74 Million By 2030

Page 1

An increase in the aging population has led to the growing demand for the development of easy to swallow pills for the elderly. The 3D printed highly soluble and easy to swallow drugs can help the elderly who have difficulty swallowing. Moreover, according to the United Nations, the number of people aged 65 and more in 2050 is projected to be 1.5 billion. Thus, the growing elderly population across the world would propel the demand for easy to swallow drugs resulting in market growth.

Other factors such as quickly expanding demand for pharmaceuticals, technical improvements in healthcare, as well as the government's focus and expenditures in the 3D printing industry, are also contributing to the market's growth. For instance, in March 2022, Evonik Venture Capital invested in Nevada based Laxxon Medical for the manufacturing of 3D printed tablets. The latter company has developed a 3D screen printing technology for the production of structured tablets with the controlled release of API over time. Such investments are likely to supplement the market growth in the coming years.

Share, Trend, Outlook & Forecast 2022 - 2030

3D Printed Drugs Market Growth & Trends

The global 3D printed drugs market is expected to reach USD 269.74 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.32% from 2022 to 2030. The rising prevalence of chronic diseases, combined with the rising population of patients with dysphagia around the globe is pushing the demand for immediate soluble medications, which is likely to drive the market. For instance, according to a study published in April 2022, the prevalence of oropharyngeal dysphagia is high in conditions such as stroke and aging and is reported to be 26.19% in the elderly.

3D Printed Drugs Market Analysis, Size, Growth,

 Inkjet

Browse full report with Table of Content (PDF with All Related Graph and Chart) @: https://www.grandviewresearch.com/industry analysis/3d printed drugs market report

 Orthopedic  Neurology

The Asia Pacific is expected to grow considerably in the future owing to the rising prevalence of chronic diseases and the presence of key players.

By application, the neurology segment held a larger share of the global market. This is attributed to an increase in the proportion of older people, which is at an increased risk of developing neurological disorders and hence, propelling the market growth.

The inkjet printer segment is expected to grow lucratively during the forecast period. Due to the 3D medications can be personalized to each patient's needs, assisting them far more than batch produced medicines, their demand is expected to skyrocket in the coming years.

3D Printed Drugs Market Report Highlights

By end use, the hospitals & clinics segment held a larger share in 2021, owing to the growing demand for personalized medicines and the cost effective use of bio drugs employing this technology.

By technology, the zip dose segment held the largest share of the 3D market. This is attributed to the increase in the requirement for rapid soluble drugs that disperse quickly in the mouth, which in turn is likely to increase the adoption and anticipate market growth.

GrandViewResearchhassegmentedtheglobal3Dprinteddrugsmarketbasedon technology,application,end user,andregion:

 FusedDepositionModeling  Stereolithography  ZipDoseTechnology Application Scope

Technology Scope Outlook (Revenue, USD Million, 2018 2030) Printing Outlook (Revenue, USD Million, 2018 - 2030)

3D Printed Drugs Market Segmentation

A few of the key market players include 3D Printer Drug Machine, Aprecia Pharmaceuticals, BV LLC, Hewlett Packard Caribe, and others.

North America dominated the global market in 2021 due to the availability of technologically advanced healthcare research framework, the presence of high R&D investment, and the development of 3D printed drugs in the region.

Regional Scope Outlook (Revenue, USD Million, 2018 2030) NorthAmerica U.S. Canada Europe U.K.

o

For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry analysis/3d printed drugs market report/request/rs1

o

Dental Others

End use Scope Outlook (Revenue, USD Million, 2018 2030) Hospitals&Clinics ResearchLaboratories Others

o Germany o France o Italy o Spain  AsiaPacific o Japan o China o India o SouthKorea  LatinAmerica o Brazil o Mexico  MiddleEast&Africa o SouthAfrica o SaudiArabia

o

List of Key Players in the 3D Printed Drugs Market Pharmaceuticals PharmaceuticalsLLC Plc Ltd PackardCaribe Pharmaceuticals

 GlaxoSmithKline

A strong research methodology was followed to collect data for the report. The data collected in this way are subjected to several quality checks to provide the best quality.

 Hewlett

The latest information on how the market is evolving to formulate their sales and marketing strategies. This Market report has been created to provide its readers with up to date information and analysis to uncover emerging opportunities for growth.

 Merck  Cycle

The Report has a vast data store, so it can accommodate your custom needs as well.

For Requesting a Free Consultation @ https://www.grandviewresearch.com/request free consultation/452982/rfc

Highlights Points of the Market:

The analysts also emphasize on the key trends and the future opportunities that can be explored in the region than can help companies in revenue expansion.

 Aprecia

The report provides a holistic view of the competitive scenario 3D Printed Drugs Market.

The data analysis in the report will help you understand the 3D Printed Drugs Market dynamics projected from 2022 2030

 Aprecia  ExtendBiosciences  Bioduro  AffinityTherapeutics  Osmotica

Why Purchase this Report?

The market report covers the key challenges, competitive landscape, and demographic analysis that can help companies get insight into the country specific variations.

 FabRx

 The latest product launches, along with technological changes and developments, are included in the report.

 AstraZeneca

Grand View Research is a full time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.

About Grand View Research

To gain competitive intelligence about leading companies with information about their market share and growth rates.

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
3D Printed Drugs Market Size Worth $269.74 Million By 2030 by Grand View Research Research - Issuu